Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy

Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy

Ploysyne Rattanakaemakorn, Prinpat Pinyowiwat, Wimolsiri Iamsumang, Kumutnart Chanprapaph, Poonkiat Suchonwanit Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Poonkiat Suchonwanit; Kumutnart Chanprapaph...

Full description

Bibliographic Details
Main Authors: Rattanakaemakorn P, Pinyowiwat P, Iamsumang W, Chanprapaph K, Suchonwanit P
Format: Article
Language:English
Published: Dove Medical Press 2021-05-01
Series:Drug Design, Development and Therapy
Subjects:
cirrhosis
combination therapy
drug
liver fibrosis
liver injury
non-alcoholic steatohepatitis
Online Access:https://www.dovepress.com/incidence-and-risk-factors-of-hepatic-fibrosis-in-psoriatic-patients-r-peer-reviewed-fulltext-article-DDDT

Internet

https://www.dovepress.com/incidence-and-risk-factors-of-hepatic-fibrosis-in-psoriatic-patients-r-peer-reviewed-fulltext-article-DDDT

Similar Items